Avita Medical Ltd (RCEL)

[MoneyGrubber13]

Interestingly, if you look at the Avita Corporate Presentation which on page 5 (currently), they indicate that the U.S. TAM 158,000 patients (per year?), while the report you cite indicates that there are over 2 million people in Japan with vitiligo, which seems to be an enormous market opportunity compared to the U.S. In summary, total # of sales of RECELL kits for treatment of vitiligo in Japan could be enormous compared to the U.S.